Karas Eric bought SPRY
January 2, 2024 · Form 4 insider transaction
Karas Eric bought 200,000 shares of ARS Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
200,000
Price
$0.00
Total value
N/A
InsiderKaras Eric
RoleOfficer
SecurityStock option (right to buy)
Transaction codeA: Grant or award
Transaction dateJanuary 2, 2024
Filing dateJanuary 4, 2024
Shares owned after200,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
25% of the shares subject to the option shall vest on January 1, 2025, and the remaining shares will vest monthly thereafter over three years.